France
# |
Name |
Total Assets |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 139.58 B
|
Dec. 31, 2023 | USD 96.09 | -1.23% |
|
France |
|
2 |
USD 507.79 M
|
Dec. 31, 2023 | USD 2.16 | -2.19% |
|
France |
|
3 |
USD 182.99 M
|
Dec. 31, 2023 | USD 4.64 | -14.23% |
|
France |
|
4 |
USD 90.57 M
|
Dec. 31, 2023 | USD 6.91 | 0.46% |
|
France |
|
5 |
USD 58.02 M
|
Dec. 31, 2023 | USD 0.96 | -6.39% |
|
France |
The Vaccines company in France with the highest Total Assets is Sanofi (Paris Stock Exchange: SAN.PA) at USD 139.58 B.
The Vaccines company in France with the lowest Total Assets is Neovacs S.A. (Paris Stock Exchange: ALNEV.PA) at USD 58.02 M.
The top 10 Vaccines companies in France by Total Assets are Sanofi, Valneva SE, DBV Technologies S.A., OSE Immunotherapeutics SA and Neovacs S.A..
The bottom 10 Vaccines companies in France by Total Assets are Neovacs S.A., OSE Immunotherapeutics SA, DBV Technologies S.A., Valneva SE and Sanofi.